Base Treatment Decisions in Metastatic Breast Cancer on Presence of ESR1 Mutations

Watchdoq January 2, 2025
(MedPage Today) -- In this exclusive MedPage Today video, Virginia Kaklamani, MD, DSc, of UT Health Sciences Center in San Antonio and co-director of the San Antonio Breast Cancer Symposium (SABCS), discusses a subgroup analysis of the phase III...

Read Full Article